Key result
The MitraClip offers a minimally invasive alternative to open surgical repair or replacement for managing patients with significant mitral regurgitation.
This review provides an overview of percutaneous mitral valve repair (MitraClip) as a minimally invasive alternative to surgery for patients with significant mitral regurgitation.
MitraClip offers a minimally invasive alternative for high-risk mitral regurgitation; leaves open need for randomized durability data.
Mitral valve disease affects more than 4 million people in the United States. The gold standard of treatment in these patients is surgical repair or replacement of the valve with a prosthesis. The MitraClip (Abbott Vascular, Menlo Park, CA) is a new technology, which offers an alternative to open surgical repair or replacement via a minimally invasive route. We present an evidence-based clinical update that provides an overview of this technology as it relates to managing patients with significant mitral regurgitation. This review article is particularly useful to noninterventional cardiologists and interventional cardiologists who will be managing patients with this novel technology in increased volumes over the next decade but who do not perform this procedure.
No takes yet. Share an insight, caveat, or question.
Kelley et al. (2016) conducted a review in mitral regurgitation. MitraClip vs. open surgical repair or replacement was evaluated. The MitraClip offers a minimally invasive alternative to open surgical repair or replacement for managing patients with significant mitral regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: